Regulation of in vivo fate of exosomes for therapeutic applications: New frontier in nanomedicines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of in vivo fate of exosomes for therapeutic applications: New frontier in nanomedicines

Published:2022-08 Issue: Volume:348 Page:483-488
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Park Jae Hyung

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Targeting strategies for tissue-specific drug delivery;Zhao;Cell,2020

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA-Cancer J. Clin,2021

3. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review;Maeda;J. Control. Release,2000

4. Hyaluronic acid–based activatable nanomaterials for stimuli-responsive imaging and therapeutics: beyond CD44-mediated drug delivery;Choi;Adv. Mater.,2019

5. Recent advances in stimuli-responsive polymer systems for remotely controlled drug release;Zhang;Prog. Polym. Sci.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy;Journal of Colloid and Interface Science;2024-10

2. Forty years Journal of Controlled Release: ‘Quality is not an act, it is a habit’;Journal of Controlled Release;2024-09

3. Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy;Bioactive Materials;2024-08

4. Shape Engineering of Exosomes for Endoplasmic Reticulum-Targeted Delivery and Amplified Anticancer Efficacy;Nano Today;2024-08

5. Biomimetic, folic acid-modified mesoporous silica nanoparticles with “stealth” and “homing” capabilities for tumor therapy;Materials & Design;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3